Skip to main content
Top
Published in: Neuroradiology 10/2006

01-10-2006 | Functional Neuroradiology

Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging

Authors: Bei Ding, Hua Wei Ling, Ke Min Chen, Hong Jiang, Yan Bo Zhu

Published in: Neuroradiology | Issue 10/2006

Login to get access

Abstract

Introduction

Regional cerebral blood volume (rCBV) and permeability surfaces (rPS) permit in vivo assessment of glioma microvasculature, which provides quite important pathophysiological information in grading gliomas. The aim of our study was to simultaneously examine rCBV and rPS in glioma patients to determine their correlation with histological grade using CT perfusion imaging.

Methods

A total of 22 patients with gliomas underwent multislice CT perfusion imaging preoperatively. Low-grade and high-grade groups were categorized corresponding to WHO grade II gliomas and WHO grade III or IV gliomas, respectively, as determined by histopathological examination. rCBVs and rPSs were obtained from regions of maximal abnormality in tumor parenchyma on CBV and PS color perfusion maps. Perfusion parameters were compared using the Kruskal-Wallis test in order to evaluate the differences in relation to tumor grade. The Pearson coefficients of rCBV and rPS for each tumor grade were assessed using SPSS 13.0 software.

Results

rCBV and rPS provided significant P-value in differentiating glioma grade (low-grade gliomas 3.28±2.01 vs 2.12±3.19 ml/100 g/min, high-grade gliomas 8.87±4.63 vs 12.11±3.18 ml/100 g/min, P<0.05). Receiver operating characteristic (ROC) curves revealed better specificity and sensitivity in PS than in CBV for glioma grade. A significant correlation between rCBV and rPS was observed in high-grade gliomas (r=0.684). rCBVs in oligodendrogliomas were higher than in other low-grade gliomas, whereas their rPS values did not show a parallel difference.

Conclusion

Perfusion CT provides useful information for glioma grading and might have the potential to significantly impact clinical management and follow-up of cerebral gliomas.
Literature
2.
go back to reference Miles KA, Charnsangavej C, Lee FT et al (2000) Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 7:840–850PubMedCrossRef Miles KA, Charnsangavej C, Lee FT et al (2000) Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 7:840–850PubMedCrossRef
3.
go back to reference Gillard JH, Antoun NM, Burnet NG et al (2001) Reproducibility of quantitative CT perfusion imaging. Br J Radiol 74:552–555PubMed Gillard JH, Antoun NM, Burnet NG et al (2001) Reproducibility of quantitative CT perfusion imaging. Br J Radiol 74:552–555PubMed
4.
go back to reference Gillard JH, Minhas P, Hayball MP et al (2000) Assessment of quantitative computed tomographic cerebral perfusion imaging with H2 15O positron emission tomography. Neurol Res 22:457–464PubMed Gillard JH, Minhas P, Hayball MP et al (2000) Assessment of quantitative computed tomographic cerebral perfusion imaging with H2 15O positron emission tomography. Neurol Res 22:457–464PubMed
5.
go back to reference Figarella-Branger D, Bouvier C (2005) Histological classification of human gliomas: state of art and controversies. Bull Cancer 92:301–309PubMed Figarella-Branger D, Bouvier C (2005) Histological classification of human gliomas: state of art and controversies. Bull Cancer 92:301–309PubMed
6.
go back to reference Smith JS, Perry A, Borell TJ et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636–645PubMed Smith JS, Perry A, Borell TJ et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636–645PubMed
7.
go back to reference Thiessen B, Maguire JA, McNeil K (2003) Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity. J Neurooncol 64:271–278PubMedCrossRef Thiessen B, Maguire JA, McNeil K (2003) Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity. J Neurooncol 64:271–278PubMedCrossRef
8.
go back to reference Thorpe PE, Chaplin DJ, Blakey DC (2003) The first international conference on vascular targeting: meeting overview. Cancer Res 63:1144–1147PubMed Thorpe PE, Chaplin DJ, Blakey DC (2003) The first international conference on vascular targeting: meeting overview. Cancer Res 63:1144–1147PubMed
9.
go back to reference Galbraith SM (2001) Combretastatin A4 phosphate (CA4P) reduces tumor blood flow in animals and man, demonstrated by MRI. Proc Am Soc Clin Oncol 20:278a Galbraith SM (2001) Combretastatin A4 phosphate (CA4P) reduces tumor blood flow in animals and man, demonstrated by MRI. Proc Am Soc Clin Oncol 20:278a
10.
go back to reference Shih SC, Mullen A, Abrams K et al (1999) Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem 274:15407–15414PubMedCrossRef Shih SC, Mullen A, Abrams K et al (1999) Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem 274:15407–15414PubMedCrossRef
11.
go back to reference Barker FG II, Chang SM, Huhn SL et al (1997) Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 80:936–941PubMedCrossRef Barker FG II, Chang SM, Huhn SL et al (1997) Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 80:936–941PubMedCrossRef
12.
go back to reference Scott JN, Brasher PM, Sevick RJ et al (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947–949PubMed Scott JN, Brasher PM, Sevick RJ et al (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947–949PubMed
13.
go back to reference Chaudhry IH, O’Donovan DG, Brenchley PE et al (2001) Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 39:409–415PubMedCrossRef Chaudhry IH, O’Donovan DG, Brenchley PE et al (2001) Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 39:409–415PubMedCrossRef
15.
go back to reference Toi M, Matsumoto T, Bando H (2001) Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2:667–673PubMedCrossRef Toi M, Matsumoto T, Bando H (2001) Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2:667–673PubMedCrossRef
16.
go back to reference Daumas-Duport C, Varlet P, Tucker ML (1997) Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 34:37–59PubMedCrossRef Daumas-Duport C, Varlet P, Tucker ML (1997) Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 34:37–59PubMedCrossRef
17.
18.
go back to reference Amoroso A (1997) Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review. Eur Rev Med Pharmacol Sci 1:17–25PubMed Amoroso A (1997) Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review. Eur Rev Med Pharmacol Sci 1:17–25PubMed
19.
go back to reference Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51PubMed Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51PubMed
20.
go back to reference Weidner N, Folkman J (1996) Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol 167–190 Weidner N, Folkman J (1996) Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol 167–190
21.
go back to reference Dvorak HF, Nagy JA, Feng D et al (1999) Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237:97–132PubMed Dvorak HF, Nagy JA, Feng D et al (1999) Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237:97–132PubMed
22.
go back to reference Taylor JS, Tofts PS, Port R et al (1999) MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 10:903–907PubMedCrossRef Taylor JS, Tofts PS, Port R et al (1999) MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 10:903–907PubMedCrossRef
23.
go back to reference Roberts HC, Roberts TP, Brasch RC et al (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21:891–899PubMed Roberts HC, Roberts TP, Brasch RC et al (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21:891–899PubMed
24.
go back to reference Provenzale JM, Wang GR, Brenner T et al (2002) Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 178:711–716PubMed Provenzale JM, Wang GR, Brenner T et al (2002) Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 178:711–716PubMed
25.
go back to reference Law M, Yang S, Babb JS et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746–755PubMed Law M, Yang S, Babb JS et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746–755PubMed
26.
go back to reference Griebel J, Mayr NA, de Vries A et al (1997) Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging.J Magn Reson Imaging 7:111–119PubMed Griebel J, Mayr NA, de Vries A et al (1997) Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging.J Magn Reson Imaging 7:111–119PubMed
27.
go back to reference Maia, AC Jr, Malheiros SM, da Rocha AJ et al (2005) MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 26:777–783PubMed Maia, AC Jr, Malheiros SM, da Rocha AJ et al (2005) MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 26:777–783PubMed
28.
go back to reference Jackson A, Kassner A, Annesley-Williams D et al (2002) Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 23:7–14PubMed Jackson A, Kassner A, Annesley-Williams D et al (2002) Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 23:7–14PubMed
29.
go back to reference Shin JH, Lee HK, Kwun BD et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathological grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 179:783–789PubMed Shin JH, Lee HK, Kwun BD et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathological grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 179:783–789PubMed
30.
go back to reference Aronen HJ, Perkio J (2002) Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 12:501–523PubMedCrossRef Aronen HJ, Perkio J (2002) Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 12:501–523PubMedCrossRef
31.
go back to reference Lev MH, Ozsunar Y, Henson JW et al (2004) Elevated relative cerebral blood volume of oligodendrogliomas: a confounder of glial tumor grading specificity using dynamic spin-echo MR susceptibility mapping. AJNR Am J Neuroradiol 25:214–221PubMed Lev MH, Ozsunar Y, Henson JW et al (2004) Elevated relative cerebral blood volume of oligodendrogliomas: a confounder of glial tumor grading specificity using dynamic spin-echo MR susceptibility mapping. AJNR Am J Neuroradiol 25:214–221PubMed
32.
go back to reference Diego JC, Bruce RR, Michael HL (2004) Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9:528–537CrossRef Diego JC, Bruce RR, Michael HL (2004) Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9:528–537CrossRef
33.
go back to reference Lupo JM, Cha S, Chang SM et al (2005) Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol 26:1446–1454PubMed Lupo JM, Cha S, Chang SM et al (2005) Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol 26:1446–1454PubMed
34.
go back to reference Mukonoweshuro W, Herwardkar A, Jackson A (2002) Imaging of intracranial tumours. Imaging 14:380–395 Mukonoweshuro W, Herwardkar A, Jackson A (2002) Imaging of intracranial tumours. Imaging 14:380–395
35.
go back to reference Provenzale JM, Mukundan S, Dewhirst M (2005) The role of blood-brain barrier permeability in brain tumor imaging and therapeutics. AJR Am J Roentgenol 185:763–767PubMedCrossRef Provenzale JM, Mukundan S, Dewhirst M (2005) The role of blood-brain barrier permeability in brain tumor imaging and therapeutics. AJR Am J Roentgenol 185:763–767PubMedCrossRef
Metadata
Title
Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging
Authors
Bei Ding
Hua Wei Ling
Ke Min Chen
Hong Jiang
Yan Bo Zhu
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
Neuroradiology / Issue 10/2006
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-006-0120-1

Other articles of this Issue 10/2006

Neuroradiology 10/2006 Go to the issue